PreMD Submits 510(k) Application To FDA For PREVU(x) LT
Tue, 07 Nov 2006 08:00 AM EST
... Predictive medicine company PreMD Inc. (TSX: PMD; Amex: PME) today announced that it has submitted a premarket notification or 510(k) to the U.S. Food and Drug Administration (FDA) for clearance of PREVU(x) LT, the lab-processed format of the PREVU(x) technology. [click link for full article] ...
Related Topics
- Tacrolimus ointment
- Mammography
- Carcinogens
- Pimecrolimus Cream 1%
- Dietary Guidelines
- Polymyxin B, Bacitracin, and Neomycin
- Amlodipine and Benazepril
- Thalidomide
- GFR
- Medicaid
- Migration
- Mining
- Clinical Assessment Software Application
- Food Labeling
- Testosterone Gel
- Drug Safety
- Yohimbe
- Food Labels
- Clinical Trials
- Celecoxib

Not Signed In -


